ICD-10 · PDGM grouping
C67 Malignant neoplasm of bladder
All 10 codes in the C67 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.
Codes in family
10
Can lead a claim
10
Cannot lead a claim
0
What CMS assigns to C67
All 10 codes group to MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases. None of the 10 is assigned a comorbidity subgroup. Every code can lead a claim.
Every code in C67
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| C67.0 | Malignant neoplasm of trigone of bladder | Can lead a claim | K | None |
| C67.1 | Malignant neoplasm of dome of bladder | Can lead a claim | K | None |
| C67.2 | Malignant neoplasm of lateral wall of bladder | Can lead a claim | K | None |
| C67.3 | Malignant neoplasm of anterior wall of bladder | Can lead a claim | K | None |
| C67.4 | Malignant neoplasm of posterior wall of bladder | Can lead a claim | K | None |
| C67.5 | Malignant neoplasm of bladder neck | Can lead a claim | K | None |
| C67.6 | Malignant neoplasm of ureteric orifice | Can lead a claim | K | None |
| C67.7 | Malignant neoplasm of urachus | Can lead a claim | K | None |
| C67.8 | Malignant neoplasm of overlapping sites of bladder | Can lead a claim | K | None |
| C67.9 | Malignant neoplasm of bladder, unspecified | Can lead a claim | K | None |
Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.
The monthly home health regs digest
What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue